GlassScriptPhysician profile
Karan Julka
NPI 1811963184
$91,567.01
in general payments reported to CMS, 2019-2025
43 companies · $23K in 2025
The $23K reported for 2025 was more than what 95% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,486 · 2020: $402 · 2021: $1,181 · 2022: $12K · 2023: $19K · 2024: $34K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $65K · Food and Beverage: $8,058 · Travel and Lodging: $2,325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $65,210.00 |
| Food and Beverage | $8,057.73 |
| Travel and Lodging | $2,325.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $78,216.06 | 2019-2025 | Breztri, Airsupra |
| Intuitive Surgical, INC. | $1,811.15 | 2019 | |
| Glaxosmithkline, LLC. | $1,805.12 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Medical Device Business Services, INC. | $1,756.97 | 2024 | Monarch |
| Ethicon INC. | $1,412.65 | 2019-2023 | Monarch Platform |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,039.42 | 2019-2025 | Ofev, Jascayd |
| Actelion Pharmaceuticals US, INC. | $879.81 | 2020-2025 | Uptravi, Opsumit, Opsynvi |
| Regeneron Healthcare Solutions, INC. | $588.73 | 2019-2025 | Dupixent |
| Inspire Medical Systems, INC. | $535.23 | 2023-2025 | Inspire |
| United Therapeutics Corporation | $514.74 | 2019-2025 | Tyvaso, Orenitram, Tyvaso |
| Genzyme Corporation | $474.22 | 2019-2025 | |
| Grifols USA, LLC | $361.51 | 2019-2024 | Prolastin-C Liquid |
| Insmed, INC. | $336.95 | 2019-2024 | Arikayce |
| Myriad Genetic Laboratories, INC. | $293.26 | 2023-2025 | Prolaris, Myrisk |
| Amgen INC. | $263.78 | 2021-2024 | Tezspire |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $199.86 | 2020-2024 | Xarelto |
| Harmony Biosciences LLC | $178.70 | 2023-2025 | Wakix |
| Merck Sharp & Dohme LLC | $117.36 | 2022-2024 | Belsomra, Winrevair |
| Csl Behring | $72.42 | 2023-2025 | Kcentra |
| Mylan Specialty L.P. | $59.41 | 2019-2020 | |
| Verona Pharma, INC. | $55.52 | 2025 | Ohtuvayre |
| Electromed, INC. | $50.05 | 2021-2024 | Smartvest |
| Pulmonx Corporation | $49.71 | 2024-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Gilead Sciences, INC. | $48.89 | 2021-2022 | |
| Mallinckrodt Enterprises LLC | $41.48 | 2019 | |
| Shire North American Group INC | $38.52 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $35.68 | 2025 | Lumryz |
| Bluewind Medical | $34.00 | 2025 | Revi |
| Ethicon US, LLC | $32.32 | 2024 | Surgicel Nu-Knit |
| Mallinckrodt Hospital Products INC. | $28.60 | 2025 | Acthar |
| Medtronic, INC. | $28.02 | 2021-2024 | Signia |
| Janssen Biotech, INC. | $20.22 | 2023 | Rybrevant |
| Teva Pharmaceuticals USA, INC. | $20.04 | 2022 | |
| Sunovion Pharmaceuticals INC. | $19.90 | 2019 | |
| Davol INC. | $19.72 | 2022 | |
| Daiichi Sankyo INC. | $18.81 | 2019 | |
| Baxter Healthcare | $17.46 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Innovation Technologies INC | $17.04 | 2025 | Irrisept |
| Boston Scientific Corporation | $16.82 | 2024 | Lithovue |
| Philips North America LLC | $15.57 | 2025 | Vest Therapy Und |
| Takeda Pharmaceuticals U.S.A., INC. | $15.25 | 2021 | |
| Hologic Sales and Service, LLC | $14.34 | 2023 | Coolseal Generator |
| Genentech USA, INC. | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karan Julka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.